Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Thioredoxin regulates Mta1 modulation of MMP-9<br />
transcription in MDA-MB-231 breast cancer cells<br />
Lucia Cappabianca 1 , Antonietta R. Farina 1 , Antonella Tacconelli 1 ,<br />
Giuseppina De Santis 1 , Kathryn Tonissen 2 , Alberto Gulino 3 and<br />
Andrew R. Mackay 1,*<br />
1<br />
Dept. of Experimental Medicine, University of L’Aquila, L’Aquila, Italy; 2 School of<br />
Biomolecular Science, Griffith University, Australia; 3 Dept. of General Pathology, University<br />
of Rome “La Sapienza”, Rome, Italy<br />
The highly malignant human breast cancer cell line MDA-MB-231 exhibits<br />
constitutive co-expression of invasion and metastasis-associated genes thioredoxin<br />
(trx), matrix metalloproteinase (MMP)-9 and metastasis associated gene (Mta)-1,<br />
which paradoxically is a repressor of MMP-9 transcriptional. Here, we identify a<br />
functional link between trx and Mta1 proteins that affects Mta1 regulation of MMP-<br />
9 transcription. We show that Mta1 is a substrate for trx and that trx stimulates and<br />
dominant negative C32S/C35S mutated trx inhibits MMP-9 transcription in MDA-MB-<br />
231 cells by a mechanism involving the regulation of Mta1/HDAC recruitment to<br />
the MMP-9 promoter in vivo. The data helps to explain the nuclear localisation and<br />
co-expression of Mta1 with MMP-9 in this highly malignant breast cancer cell line.<br />
A potential therapeutic use for Trx inhibitors and regulators of HDAC activity in the<br />
treatment of malignant breast cancer will be discussed.<br />
76p5